Agenzia italiana del farmaco

Vaccinare per il Covid-19 gli adolescenti: le ragioni e le parole da dire

Marchetti F

2021/6 — pag. 349-349 — DOI

Storia delle evidenze sull’uso pediatrico dei farmaci antiemetici

F. Marchetti

2019/6 — pag. 365-369

On 2nd May 2019 the Italian Medicines Agency (AIFA) issued an “Informative Note agreed upon with the European Regulatory Authorities” on domperidone entitled Memorandum on recommendations for minimising heart risks and eliminating prescriptions in ...

Sicurezza ed efficacia dei mucolitici in età pediatrica

L. Tartaglia, F. Trotta e i componenti del Working Group Pediatrico dell’AIFA

2011/2 — pag. 110-113

Following a signal from France, which showed an increase in the cases of bronchial obstruction and worsening respiratory disorders in children under 2 years of age treated with mucolytics, the Italian Drug Agency (AIFA) has revised the risk/benefit...